Promising hair loss drug trial for teens could restore confidence
Disease control
Recruiting now
This study tests a drug called deuruxolitinib in teenagers aged 12 to 18 who have lost at least half of their scalp hair due to alopecia areata. The goal is to see if the drug can safely regrow hair, with some participants receiving a placebo for comparison. After the main study,…
Phase: PHASE3 • Sponsor: Sun Pharmaceutical Industries, Inc. • Aim: Disease control
Last updated May 01, 2026 15:59 UTC